China Antidiabetic SGLT-2 Inhibitor Market Research Report 2017

January 2017 | 106 pages | ID: C7408F8DDEBEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antidiabetic SGLT-2 Inhibitor

Revenue, means the sales value of Antidiabetic SGLT-2 Inhibitor

This report studies Antidiabetic SGLT-2 Inhibitor in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Anderson Hay & Grain Inc.
• Border Valley
• Sanofi
• Johnson & Johnson
• Bristol-Myers Squibb
• AstraZeneca
• Boehringer Ingelheim
• GlaxoSmithKline
• Pfizer
• Takeda Pharmaceuticals
• Eli Lilly
• Merck & Co.
• Novo Nordisk

Market Segment by Regions (provinces), covering

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Canagliflozin
• Empagliflozin
• Dapagliflozin

Split by Application, this report focuses on consumption, market share and growth rate of Antidiabetic SGLT-2 Inhibitor in each application, can be divided into

• Hospital
• Clinic

Contents

China Antidiabetic SGLT-2 Inhibitor Market Research Report 2017

1 ANTIDIABETIC SGLT-2 INHIBITOR MARKET OVERVIEW

1.1 Product Overview and Scope of Antidiabetic SGLT-2 Inhibitor
1.2 Antidiabetic SGLT-2 Inhibitor Segment by Type
  1.2.1 China Production Market Share of Antidiabetic SGLT-2 Inhibitor Type in 2015
  1.2.2 Canagliflozin
  1.2.3 Empagliflozin
  1.2.4 Dapagliflozin
1.3 Applications of Antidiabetic SGLT-2 Inhibitor
  1.3.1 Antidiabetic SGLT-2 Inhibitor Consumption Market Share by Application in 2015
  1.3.2 Hospital
  1.3.3 Clinic
1.4 China Market Size (Value) of Antidiabetic SGLT-2 Inhibitor (2011-2021)
1.5 China Antidiabetic SGLT-2 Inhibitor Status and Outlook
1.6 Government Policies

2 CHINA ANTIDIABETIC SGLT-2 INHIBITOR MARKET COMPETITION BY MANUFACTURERS

2.1 China Antidiabetic SGLT-2 Inhibitor Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Antidiabetic SGLT-2 Inhibitor Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Antidiabetic SGLT-2 Inhibitor Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Antidiabetic SGLT-2 Inhibitor Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antidiabetic SGLT-2 Inhibitor Market Competitive Situation and Trends
  2.5.1 Antidiabetic SGLT-2 Inhibitor Market Concentration Rate
  2.5.2 Antidiabetic SGLT-2 Inhibitor Market Share of Top 3 and Top 5 Manufacturers

3 CHINA ANTIDIABETIC SGLT-2 INHIBITOR MANUFACTURERS PROFILES/ANALYSIS

3.1 Anderson Hay & Grain Inc.
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
    3.1.2.1 Canagliflozin
    3.1.2.2 Empagliflozin
  3.1.3 Anderson Hay & Grain Inc. Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Border Valley
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
    3.2.2.1 Canagliflozin
    3.2.2.2 Empagliflozin
  3.2.3 Border Valley 106 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Sanofi
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
    3.3.2.1 Canagliflozin
    3.3.2.2 Empagliflozin
  3.3.3 Sanofi 118 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Johnson & Johnson
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
    3.4.2.1 Canagliflozin
    3.4.2.2 Empagliflozin
  3.4.3 Johnson & Johnson Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Bristol-Myers Squibb
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
    3.5.2.1 Canagliflozin
    3.5.2.2 Empagliflozin
  3.5.3 Bristol-Myers Squibb Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 AstraZeneca
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
    3.6.2.1 Canagliflozin
    3.6.2.2 Empagliflozin
  3.6.3 AstraZeneca Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Boehringer Ingelheim
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
    3.7.2.1 Canagliflozin
    3.7.2.2 Empagliflozin
  3.7.3 Boehringer Ingelheim Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 GlaxoSmithKline
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
    3.8.2.1 Canagliflozin
    3.8.2.2 Empagliflozin
  3.8.3 GlaxoSmithKline Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 Pfizer
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
    3.9.2.1 Canagliflozin
    3.9.2.2 Empagliflozin
  3.9.3 Pfizer Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview
3.10 Takeda Pharmaceuticals
  3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.10.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
    3.10.2.1 Canagliflozin
    3.10.2.2 Empagliflozin
  3.10.3 Takeda Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.10.4 Main Business/Business Overview
3.11 Eli Lilly
3.12 Merck & Co.
3.13 Novo Nordisk

4 CHINA ANTIDIABETIC SGLT-2 INHIBITOR CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Antidiabetic SGLT-2 Inhibitor Capacity, Production and Growth (2011-2016)
4.2 China Antidiabetic SGLT-2 Inhibitor Revenue and Growth (2011-2016)
4.3 China Antidiabetic SGLT-2 Inhibitor Production, Consumption, Export and Import (2011-2016)

5 CHINA ANTIDIABETIC SGLT-2 INHIBITOR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Antidiabetic SGLT-2 Inhibitor Production and Market Share by Type (2011-2016)
5.2 China Antidiabetic SGLT-2 Inhibitor Revenue and Market Share by Type (2011-2016)
5.3 China Antidiabetic SGLT-2 Inhibitor Price by Type (2011-2016)
5.4 China Antidiabetic SGLT-2 Inhibitor Production Growth by Type (2011-2016)

6 CHINA ANTIDIABETIC SGLT-2 INHIBITOR MARKET ANALYSIS BY APPLICATION

6.1 China Antidiabetic SGLT-2 Inhibitor Consumption and Market Share by Application (2011-2016)
6.2 China Antidiabetic SGLT-2 Inhibitor Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CHINAANTIDIABETIC SGLT-2 INHIBITOR MARKET ANALYSIS BY REGIONS (PROVINCES)

7.1 China Antidiabetic SGLT-2 Inhibitor Production, Production Value and Price by Regions (Provinces)(2011-2016)
  7.1.1 China Antidiabetic SGLT-2 Inhibitor Production and Market Share by Regions (Provinces)(2011-2016)
  7.1.2 China Antidiabetic SGLT-2 Inhibitor Production Value and Market Share by Regions (Provinces)(2011-2016)
  7.1.3 China Antidiabetic SGLT-2 Inhibitor Sales Price by Regions (Provinces)(2011-2016)
7.2 China Antidiabetic SGLT-2 Inhibitor Consumption by Regions (Provinces)(2011-2016)
7.3 China Antidiabetic SGLT-2 Inhibitor Production, Consumption, Export and Import (2011-2016)

8 ANTIDIABETIC SGLT-2 INHIBITOR MANUFACTURING COST ANALYSIS

8.1 Antidiabetic SGLT-2 Inhibitor Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antidiabetic SGLT-2 Inhibitor

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Antidiabetic SGLT-2 Inhibitor Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antidiabetic SGLT-2 Inhibitor Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 CHINA ANTIDIABETIC SGLT-2 INHIBITOR MARKET FORECAST (2016-2021)

12.1 China Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Antidiabetic SGLT-2 Inhibitor Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Antidiabetic SGLT-2 Inhibitor Production Forecast by Type (2016-2021)
12.4 China Antidiabetic SGLT-2 Inhibitor Consumption Forecast by Application (2016-2021)
12.5 China Antidiabetic SGLT-2 Inhibitor Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  12.5.1 China Antidiabetic SGLT-2 Inhibitor Production Forecast by Regions (Provinces)(2016-2021)
  12.5.2 China Antidiabetic SGLT-2 Inhibitor Consumption Forecast by Regions (Provinces)(2016-2021)
  12.5.3 China Antidiabetic SGLT-2 Inhibitor Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Antidiabetic SGLT-2 Inhibitor Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetic SGLT-2 Inhibitor
Figure China Production Market Share of Antidiabetic SGLT-2 Inhibitor by Type in 2015
Figure Product Picture of Canagliflozin
Table Major Manufacturers of Canagliflozin
Figure Product Picture of Empagliflozin
Table Major Manufacturers of Empagliflozin
Figure Product Picture of Dapagliflozin
Table Major Manufacturers of Dapagliflozin
Table Antidiabetic SGLT-2 Inhibitor Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure China Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2011-2021)
Table China Antidiabetic SGLT-2 Inhibitor Capacity of Key Manufacturers (2015 and 2016)
Table China Antidiabetic SGLT-2 Inhibitor Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Antidiabetic SGLT-2 Inhibitor Capacity of Key Manufacturers in 2015
Figure China Antidiabetic SGLT-2 Inhibitor Capacity of Key Manufacturers in 2016
Table China Antidiabetic SGLT-2 Inhibitor Production of Key Manufacturers (2015 and 2016)
Table China Antidiabetic SGLT-2 Inhibitor Production Share by Manufacturers (2015 and 2016)
Figure 2015 Antidiabetic SGLT-2 Inhibitor Production Share by Manufacturers
Figure 2016 Antidiabetic SGLT-2 Inhibitor Production Share by Manufacturers
Table China Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Antidiabetic SGLT-2 Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Antidiabetic SGLT-2 Inhibitor Revenue Share by Manufacturers
Table 2016 China Antidiabetic SGLT-2 Inhibitor Revenue Share by Manufacturers
Table China Market Antidiabetic SGLT-2 Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Antidiabetic SGLT-2 Inhibitor Average Price of Key Manufacturers in 2015
Table Manufacturers Antidiabetic SGLT-2 Inhibitor Manufacturing Base Distribution and Sales Area
Table Manufacturers Antidiabetic SGLT-2 Inhibitor Product Type
Figure Antidiabetic SGLT-2 Inhibitor Market Share of Top 3 Manufacturers
Figure Antidiabetic SGLT-2 Inhibitor Market Share of Top 5 Manufacturers
Table Anderson Hay & Grain Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Anderson Hay & Grain Inc. Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Anderson Hay & Grain Inc. Antidiabetic SGLT-2 Inhibitor Market Share (2011-2016)
Table Border Valley Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Border Valley Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Border Valley Antidiabetic SGLT-2 Inhibitor Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Antidiabetic SGLT-2 Inhibitor Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Antidiabetic SGLT-2 Inhibitor Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Antidiabetic SGLT-2 Inhibitor Market Share (2011-2016)
Table Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Antidiabetic SGLT-2 Inhibitor Capacity, Production and Growth (2011-2016)
Figure China Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth (2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Production, Consumption, Export and Import (2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Production by Type (2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Production Share by Type (2011-2016)
Figure Production Market Share of Antidiabetic SGLT-2 Inhibitor by Type (2011-2016)
Figure 2015 Production Market Share of Antidiabetic SGLT-2 Inhibitor by Type
Table China Antidiabetic SGLT-2 Inhibitor Revenue by Type (2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Antidiabetic SGLT-2 Inhibitor by Type (2011-2016)
Figure 2015 Revenue Market Share of Antidiabetic SGLT-2 Inhibitor by Type
Table China Antidiabetic SGLT-2 Inhibitor Price by Type (2011-2016)
Figure China Antidiabetic SGLT-2 Inhibitor Production Growth by Type (2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Consumption by Application (2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Consumption Market Share by Application (2011-2016)
Figure China Antidiabetic SGLT-2 Inhibitor Consumption Market Share by Application in 2015
Table China Antidiabetic SGLT-2 Inhibitor Consumption Growth Rate by Application (2011-2016)
Figure China Antidiabetic SGLT-2 Inhibitor Consumption Growth Rate by Application (2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Production by Regions (Provinces)(2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Production Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Production Value by Regions (Provinces)(2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Sales Price by Regions (Provinces)(2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Consumption by Regions (Provinces)(2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetic SGLT-2 Inhibitor Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetic SGLT-2 Inhibitor
Figure Manufacturing Process Analysis of Antidiabetic SGLT-2 Inhibitor
Figure Antidiabetic SGLT-2 Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetic SGLT-2 Inhibitor Major Manufacturers in 2015
Table Major Buyers of Antidiabetic SGLT-2 Inhibitor
Table Distributors/Traders List
Figure China Antidiabetic SGLT-2 Inhibitor Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate Forecast (2016-2021)
Table China Antidiabetic SGLT-2 Inhibitor Production, Import, Export and Consumption Forecast (2016-2021)
Table China Antidiabetic SGLT-2 Inhibitor Production Forecast by Type (2016-2021)
Table China Antidiabetic SGLT-2 Inhibitor Consumption Forecast by Application (2016-2021)
Table China Antidiabetic SGLT-2 Inhibitor Production Forecast by Regions (Provinces)(2016-2021)
Table China Antidiabetic SGLT-2 Inhibitor Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Antidiabetic SGLT-2 Inhibitor Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)